Le carcinome médullaire de la thyroïde: les nouvelles approches thérapeutiques

This publication has 40 references indexed in Scilit:

• Survival Improvement in Patients With Medullary Thyroid Carcinoma Who Undergo Pretargeted Anti–Carcinoembryonic-Antigen Radioimmunotherapy: A Collaborative Study With the French Endocrine Tumor Group
  Journal of Clinical Oncology, 2006
• BAY 43-9006 Inhibition of Oncogenic RET Mutants
  JNCI Journal of the National Cancer Institute, 2006
• Antitumoural Effects of the Pyridyl Cyanoguanidine CHS 828 on Three Different Types of Neuroendocrine Tumours Xenografted to Nude Mice
  Neuroendocrinology, 2005
• Antitumor Capacity of a Dominant-NegativeRETProto-Oncogene Mutant in a Medullary Thyroid Carcinoma Model
  Human Gene Therapy, 2003
• Effective gene therapy for medullary thyroid carcinoma using recombinant adenovirus inducing tumor-specific expression of interleukin-12
  Gene Therapy, 2002
• Combining radioimmunotherapy and chemotherapy for treatment of medullary thyroid carcinoma
  Cancer, 2001
• Genetic immunotherapy of established tumours with adenoviral vectors transducing murine interleukin-12 (mIL12) subunits in a rat medullary thyroid carcinoma model
  Clinical Endocrinology, 2000
• Gene Therapy of Established Medullary Thyroid Carcinoma with Herpes Simplex Viral Thymidine Kinase in a Rat Tumor Model: Relationship of Bystander Effect and Antitumor Efficacy
  Thyroid®, 2000
• Genetic Immunotherapy for Medullary Thyroid Carcinoma: Destruction of Tumors in Mice by In Vivo Delivery of Adenoviral Vector Transducing the Murine Interleukin-2 Gene
  Thyroid®, 1998
• Medullary Thyroid Cancer: Analyses of Survival and Prognostic Factors and the Role of Radiation Therapy in Local Control
  Thyroid®, 1996